NFKB1 and metabolic dysfunction-associated steatotic liver disease: Therefore, these results suggest that SFN intervention can improve the hepatic inflammation of NAFLD by reducing LPS translocation and inhibiting the activation of its downstream TLR4/NF-κB signaling pathway.